We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STXB
5376
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
$73K ﹤0.01%
5,958
+3,172
+114% +$35.8K
FBIO icon
5377
Fortress Biotech
FBIO
$104M
$72K ﹤0.01%
1,803
+170
+10% +$6.31K
TCI icon
5378
Transcontinental Realty Investors
TCI
$352M
$72K ﹤0.01%
2,411
+334
+16% +$7.71K
BZM
5379
DELISTED
BlackRock Maryland Municipal Bond Trust
BZM
$72K ﹤0.01%
5,337
-12,714
-70% -$172K
APVO icon
5380
Aptevo Therapeutics
APVO
$5.12M
0
GMOM icon
5381
Cambria Global Momentum ETF
GMOM
$69.8M
$71K ﹤0.01%
3,000
-8,146
-73% -$188K
IMMR icon
5382
Immersion
IMMR
$251M
$71K ﹤0.01%
11,356
-295,958
-96% -$1.91M
MBCN
5383
DELISTED
Middlefield Banc Corp
MBCN
$71K ﹤0.01%
3,448
+1,842
+115% +$34.1K
SOXS icon
5384
Direxion Daily Semiconductor Bear 3X ETF
SOXS
$1.93B
0
WHG icon
5385
Westwood Holdings Group
WHG
$182M
$71K ﹤0.01%
4,463
-5,808
-57% -$110K
CRMD icon
5386
CorMedix
CRMD
$591M
$70K ﹤0.01%
11,132
-5,087
-31% -$23.6K
NCMI icon
5387
National CineMedia
NCMI
$376M
$70K ﹤0.01%
2,358
+1,433
+155% +$43.1K
OVLY icon
5388
Oak Valley Bancorp
OVLY
$285M
$70K ﹤0.01%
5,496
+1,952
+55% +$26K
MRNS
5389
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$70K ﹤0.01%
6,798
+3,385
+99% +$31.1K
CHEP
5390
DELISTED
AGFiQ U.S. Market Neutral Value Fund
CHEP
$70K ﹤0.01%
+4,764
New +$72.8K
BHV icon
5391
BlackRock Virginia Muni Bond Trust
BHV
$20.3M
$69K ﹤0.01%
4,500
CRF
5392
Cornerstone Total Return Fund
CRF
$1.16B
$69K ﹤0.01%
7,014
-6,448
-48% -$59K
METC icon
5393
Ramaco Resources Class A
METC
$599M
$69K ﹤0.01%
33,346
+4,526
+16% +$10.7K
OSW icon
5394
OneSpaWorld
OSW
$2.61B
$69K ﹤0.01%
14,575
-9,242
-39% -$50.2K
EGF
5395
DELISTED
Blackrock Enhanced Government Fund, Inc.
EGF
$69K ﹤0.01%
5,258
+1,000
+23% +$13.1K
OPNT
5396
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$69K ﹤0.01%
7,702
+3,160
+70% +$32.8K
MRBK icon
5397
Meridian
MRBK
$234M
$68K ﹤0.01%
8,642
+8,278
+2,274% +$62.9K
RIOT icon
5398
Riot Platforms
RIOT
$7.63B
$68K ﹤0.01%
30,528
-8,643
-22% -$15.5K
PTRS
5399
DELISTED
Partners Bancorp Common Stock
PTRS
$68K ﹤0.01%
+10,309
New +$71.9K
TCFC
5400
DELISTED
The Community Financial Corporation Common Stock
TCFC
$68K ﹤0.01%
2,813
+917
+48% +$20.2K

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.